par 1 antagonist fr171113 Search Results


93
Tocris par 1 antagonist fr171113
Par 1 Antagonist Fr171113, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/par 1 antagonist fr171113/product/Tocris
Average 93 stars, based on 1 article reviews
par 1 antagonist fr171113 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Fujisawa Pharmaceutical Co Ltd par1 antagonist fr171113
Par1 Antagonist Fr171113, supplied by Fujisawa Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/par1 antagonist fr171113/product/Fujisawa Pharmaceutical Co Ltd
Average 90 stars, based on 1 article reviews
par1 antagonist fr171113 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Tocris par1 antagonist, fr171113
A. SC35, SC38, and SC40 were incubated with CatG, LF, CatGinh., DMSO, CatG with LF, CatG with LF and CatG inhibitor (CatGinh.), CatG with LF and DMSO, or CatG with CatGinh. for 24h at 37°C. Cell surface expression of A . <t>PAR1</t> or B. MHC I was determined by flow cytometry. All values were normalized to the isotype control. Eight independent experiments were performed ( n = 8) and summarized in a bar diagram. SC35, SC38, and SC40 were treated with different proteases (CatG, CatS, NE, PAR3, and thrombin) for 24h at 37°C and levels of PAR1 C. or MHC I D. were analyzed by flow cytometry. Nine independent experiments were performed ( n = 9) and values were normalized to the isotype control.
Par1 Antagonist, Fr171113, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/par1 antagonist, fr171113/product/Tocris
Average 90 stars, based on 1 article reviews
par1 antagonist, fr171113 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Abbott Laboratories zo-1 tight junctions
A. SC35, SC38, and SC40 were incubated with CatG, LF, CatGinh., DMSO, CatG with LF, CatG with LF and CatG inhibitor (CatGinh.), CatG with LF and DMSO, or CatG with CatGinh. for 24h at 37°C. Cell surface expression of A . <t>PAR1</t> or B. MHC I was determined by flow cytometry. All values were normalized to the isotype control. Eight independent experiments were performed ( n = 8) and summarized in a bar diagram. SC35, SC38, and SC40 were treated with different proteases (CatG, CatS, NE, PAR3, and thrombin) for 24h at 37°C and levels of PAR1 C. or MHC I D. were analyzed by flow cytometry. Nine independent experiments were performed ( n = 9) and values were normalized to the isotype control.
Zo 1 Tight Junctions, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zo-1 tight junctions/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
zo-1 tight junctions - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Schattauer GmbH par-1 antagonist fr171113
A. SC35, SC38, and SC40 were incubated with CatG, LF, CatGinh., DMSO, CatG with LF, CatG with LF and CatG inhibitor (CatGinh.), CatG with LF and DMSO, or CatG with CatGinh. for 24h at 37°C. Cell surface expression of A . <t>PAR1</t> or B. MHC I was determined by flow cytometry. All values were normalized to the isotype control. Eight independent experiments were performed ( n = 8) and summarized in a bar diagram. SC35, SC38, and SC40 were treated with different proteases (CatG, CatS, NE, PAR3, and thrombin) for 24h at 37°C and levels of PAR1 C. or MHC I D. were analyzed by flow cytometry. Nine independent experiments were performed ( n = 9) and values were normalized to the isotype control.
Par 1 Antagonist Fr171113, supplied by Schattauer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/par-1 antagonist fr171113/product/Schattauer GmbH
Average 90 stars, based on 1 article reviews
par-1 antagonist fr171113 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


A. SC35, SC38, and SC40 were incubated with CatG, LF, CatGinh., DMSO, CatG with LF, CatG with LF and CatG inhibitor (CatGinh.), CatG with LF and DMSO, or CatG with CatGinh. for 24h at 37°C. Cell surface expression of A . PAR1 or B. MHC I was determined by flow cytometry. All values were normalized to the isotype control. Eight independent experiments were performed ( n = 8) and summarized in a bar diagram. SC35, SC38, and SC40 were treated with different proteases (CatG, CatS, NE, PAR3, and thrombin) for 24h at 37°C and levels of PAR1 C. or MHC I D. were analyzed by flow cytometry. Nine independent experiments were performed ( n = 9) and values were normalized to the isotype control.

Journal: Oncotarget

Article Title: Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells

doi: 10.18632/oncotarget.12980

Figure Lengend Snippet: A. SC35, SC38, and SC40 were incubated with CatG, LF, CatGinh., DMSO, CatG with LF, CatG with LF and CatG inhibitor (CatGinh.), CatG with LF and DMSO, or CatG with CatGinh. for 24h at 37°C. Cell surface expression of A . PAR1 or B. MHC I was determined by flow cytometry. All values were normalized to the isotype control. Eight independent experiments were performed ( n = 8) and summarized in a bar diagram. SC35, SC38, and SC40 were treated with different proteases (CatG, CatS, NE, PAR3, and thrombin) for 24h at 37°C and levels of PAR1 C. or MHC I D. were analyzed by flow cytometry. Nine independent experiments were performed ( n = 9) and values were normalized to the isotype control.

Article Snippet: In a separate experiment, PBMCs were incubated with PAR1 antagonist, FR171113 (10 mM, Tocris) for 6 h at 37°C.

Techniques: Incubation, Expressing, Flow Cytometry